Renaissance Capital logo

KIPS News

Kips Bay Medical quiet period ends March 22

Kips Bay Medical, which offers vein support technology used in coronary artery bypass surgery, will see its quiet period end on Tuesday, March 22. On February 10, the company raised $16.5 million by offering 2.1 million shares at $8, at the low end of the range...read more

Kips Bay Medical prices downsized IPO at $8, the low end of the range

Kips Bay Medical, which offers vein support technology used in coronary artery bypass surgery, raised $17 million by offering 2.1 million shares at $8, the low end of the range of $8 to $10. The company had originally expected to sell 2.75 million shares. Kips...read more

Medical device company Kips Bay Medical announces IPO terms

Kips Bay Medical, which is developing vein support technology to be used in coronary artery bypass grafting (CABG) surgery, announced terms for its IPO on Tuesday. The Minneapolis, MN-based company plans to raise $25 million by offering 2.75 million shares at a...read more

Medical device company Kips Bay Medical files for $58 million IPO

Kips Bay Medical, a medical device company developing vein support technology to be used in coronary artery bypass grafting (CABG) surgery, filed on Thursday with the SEC to raise up to $58 million in an initial public offering. The Minneapolis, MN-based...read more

Archived Headlines